Client News

Secarna Pharmaceuticals presents data at OTS showcasing unique characteristics and factors with a role in the activity and side effect profile of LNA-modified ASOs

Nature Communications publication reveals highly efficient AAV delivery of large genes using ViGeneron´s REVeRT technology

Galimedix appoints Dr. Luciana Summo as Vice President, R&D Operations

Abivax announces Closing of its Initial Public Offering on the Nasdaq Global Market

Carbios Places Sustainability at the Heart of its Governance with New Appointment to its Executive Committee

Abivax announces trading resumption of its ordinary shares on Euronext Paris

Abivax announces the pricing of its Initial Public Offering on the Nasdaq Global Market

Abivax announces temporary trading halt of its ordinary shares on Euronext Paris

Abivax announces the filing of an amended registration statement, including an estimated initial public offering price range

Mainz Biomed Presents Groundbreaking Results of ColoFuture Study